The company said its acquisition of Dupont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers.
The food safety firm is using NGS testing and data analytics to create actionable information for retailers and manufacturers.
The firms also renewed distribution agreements for DuPont's BAX System Q7 food safety testing platform in Canada, Australia and New Zealand.
The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers.
Under the terms of the agreements, Qiagen will make CosmosID's platform available as a plug in, and Trigent will supply Qiagen's software to the FDA.
At the end of the quarter, the company had 39 of its Atlas molecular testing instruments placed with customers under commercial agreements compared to 36 in Q3 2014.
The firm's analytics platform combines NGS with a big data platform and a molecular food database.
A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.
The revenue gain was the result of an increase in the number of placements of its Atlas instruments with commercial customers.
The assay is now approved for testing composited samples of ground beef.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.